Phase II evaluation of interferon-α-2a for progressive or recurrent craniopharyngiomas

Journal of Neurosurgery

Volumn 92, Issue 2, 2000, Pages 255-260

  Jakacki, Regina I ^a   Cohen, Bruce H ^b   Jamison, Cheryl ^b   Mathews, Vincent P ^b   Arenson, Edward ^b   Longee, Darryl C ^b   Hilden, Joanne ^b   Cornelius, Al ^b   Needle, Michael ^b   Heilman, Doug ^b   Boaz, Joel C ^b   Luerssen, Thomas G ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

Children; Interferon; Recurrent craniopharyngioma

Indexed keywords

RECOMBINANT ALPHA2A INTERFERON;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CRANIOPHARYNGIOMA; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TOXICITY; TUMOR RECURRENCE;

EID: 0033974141     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.92.2.0255     Document Type: Article

References (27)

1. Bunin GR, Surawicz TS, Witman PA, et al: The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547-551, 1998
2. Cavazzuti V, Fischer EG, Welch K, et al: Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 59:409-417, 1983
3. Danoff BF, Cowchock FS, Kramer S: Childhood craniopharyngioma: survival, local control, endocrine and neurologic function following radiotherapy. Int J Radiat Oncol Biol Phys 9: 171-175, 1983
4. Edwards L, Berman B, Greenway H, et al: Eradication of squamous cell carcinoma by intralesional interferon alpha 2-b therapy. J Interferon Res 11:594, 1991 (Abstract)
5. Fischer EG, Welch K. Shillito J Jr, et al: Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 73: 534-540, 1990
6. Galatzer A, Nofar E, Beit-Halachmi N, et al: Intellectual and psychosocial functions of children, adolescents and young adults before and after operation for craniopharyngioma. Child Care Health Dev 7:307-316, 1981
7. Hoffman HJ, De Silva M, Humphreys RP. et al: Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76:47-52, 1992
8. Ikic D, Padovan I, Pipic N, et al: Treatment of squamous cell carcinoma with interferon. Int J Dermatol 30:58-61, 1991
9. Lichter AS, Wara WM, Sheline GE, et al: The treatment of craniopharyngiomas. Int J Radiat Oncol Biol Phys 2: 675-683, 1977
10. Lippman SM, Parkinson DR, Itri LM, et al: 13-cis-retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84:235-241, 1992
11. Mahaley MS Jr, Urso MB, Whaley RA. et al: Immunobiology of primary intracranial tumors. Part 10: therapeutic efficacy of interferon in the treatment of recurrent gliomas. J Neurosurg 63:719-725, 1985
12. Manaka S. Teramoto A, Takakura K: The efficacy of radiotherapy for craniopharyngioma. J Neurosurg 62:648-656, 1985
13. Needle M, Molloy P, Packer R, et al: A phase II randomized trial of 13-cis retinoic acid (CRA) and interferon alfa-2A (IFN) in the treatment of plexiform neurofibroma (PN) in patients with neurofibromatosis type 1 (NFl). Pediatr Res 37:151A, 1995 (Abstract)
14. Onoyama Y, Ono K, Yabumoto E, et al: Radiation therapy of craniopharyngioma. Radiology 125:799-803, 1977
15. Regine WF, Kramer S: Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation. Int J Radiat Oncol Biol Phys 24:611-617, 1992
16. Richmond IL, Wara WM, Wilson CB: Role of radiation therapy in the management of craniopharyngiomas in children. Neurosurgery 6:513-517, 1980
17. Rodríguez-Villanueva J, McDonnell TJ: Induction of apoptotic cell death in non-melanoma skin cancer by interferon-α. Int J Cancer 61:110-114, 1995
18. Rubinstein LJ, Russell DS: Pathology of Tumours of the Nervous System, ed 5. Baltimore: Williams & Wilkins, 1990, pp 695-696
19. Sen GC, Lengyel P: The interferon system. A bird's eye view of its biochemistry. J Biol Chem 267:5017-5020, 1992
20. Sorva R: Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77:587-592, 1988
21. Stelling MW, McKay SE, Carr WA, et al: Frontal lobe lesions and cognitive function in craniopharyngioma survivors. Am J Dis Child 140:710-714, 1986
22. Sung DI, Chang CH, Harisiadis L. et al: Treatment results of craniopharyngiomas. Cancer 47:847-852, 1981
23. Wadler S. Schwartz EL: Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50:3473-3486, 1990
24. Weiss M. Sutton L, Marcial V, et al: The role of radiation therapy in the management of childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 17:1313-1321, 1989
25. Wen BC, Hussey DH, Staples J, et al: A comparison of the roles of surgery and radiation therapy in the management of craniopharyngiomas. Int J Radiat Oncol Biol Phys 16:17-24, 1989
26. Yates AJ, Stephens RE, Elder PJ, et al: Effects of interferon and gangliosides on growth of cultured human glioma and fetal brain cells. Cancer Res 45:1033-1039, 1985
27. Yung WKA, Sleek PA, Kelleher PJ, et al: Growth inhibitory effect of recombinant α and β interferon on human glioma cells. J Neurooncol 5:323-330, 1987